Bank of America’s Calithera Biosciences, Inc CALA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-539
| Closed | -$1.76K | – | 8688 |
|
|
2022
Q4 | $1.76K | Sell |
539
-1
| -0.2% | -$2 | ﹤0.01% | 7261 |
|
|
2022
Q3 | $2K | Buy |
540
+15
| +3% | +$51 | ﹤0.01% | 7627 |
|
|
2022
Q2 | $1K | Sell |
525
-105
| -17% | -$487 | ﹤0.01% | 7948 |
|
|
2022
Q1 | $5K | Sell |
630
-156
| -20% | -$1.59K | ﹤0.01% | 7920 |
|
|
2021
Q4 | $10K | Sell |
786
-1,099
| -58% | -$27.6K | ﹤0.01% | 7708 |
|
|
2021
Q3 | $82K | Sell |
1,885
-3,126
| -62% | -$135K | ﹤0.01% | 6828 |
|
|
2021
Q2 | $209K | Buy |
5,011
+2,379
| +90% | +$105K | ﹤0.01% | 6075 |
|
|
2021
Q1 | $128K | Buy |
2,632
+642
| +32% | +$37.4K | ﹤0.01% | 6288 |
|
|
2020
Q4 | $195K | Sell |
1,990
-71
| -3% | -$6.22K | ﹤0.01% | 5613 |
|
|
2020
Q3 | $142K | Sell |
2,061
-444
| -18% | -$38.7K | ﹤0.01% | 5492 |
|
|
2020
Q2 | $265K | Buy |
2,505
+1,803
| +257% | +$214K | ﹤0.01% | 5063 |
|
|
2020
Q1 | $63K | Sell |
702
-64
| -8% | -$7.62K | ﹤0.01% | 5774 |
|
|
2019
Q4 | $87K | Sell |
766
-2,234
| -74% | -$168K | ﹤0.01% | 6047 |
|
|
2019
Q3 | $185K | Sell |
3,000
-185
| -6% | -$14.8K | ﹤0.01% | 5715 |
|
|
2019
Q2 | $249K | Sell |
3,185
-690
| -18% | -$78.3K | ﹤0.01% | 5510 |
|
|
2019
Q1 | $522K | Sell |
3,875
-766
| -17% | -$80.5K | ﹤0.01% | 4986 |
|
|
2018
Q4 | $372K | Buy |
4,641
+776
| +20% | +$76.5K | ﹤0.01% | 5129 |
|
|
2018
Q3 | $405K | Buy |
3,865
+568
| +17% | +$54.1K | ﹤0.01% | 5097 |
|
|
2018
Q2 | $330K | Buy |
3,297
+151
| +5% | +$17.1K | ﹤0.01% | 5127 |
|
|
2018
Q1 | $397K | Buy |
3,146
+1,937
| +160% | +$302K | ﹤0.01% | 4982 |
|
|
2017
Q4 | $201K | Buy |
1,209
+849
| +236% | +$217K | ﹤0.01% | 5410 |
|
|
2017
Q3 | $113K | Buy |
360
+121
| +51% | +$38.2K | ﹤0.01% | 5627 |
|
|
2017
Q2 | $71K | Buy |
+239
| New | +$63.9K | ﹤0.01% | 5743 |
|
|
2016
Q3 | – | Sell |
-180
| Closed | -$13K | – | 7452 |
|
|
2016
Q2 | $13K | Buy |
+180
| New | +$18K | ﹤0.01% | 6416 |
|
|
2016
Q1 | – | Sell |
-13
| Closed | -$2K | – | 7439 |
|
|
2015
Q4 | $2K | Buy |
13
+12
| +1,200% | +$1.8K | ﹤0.01% | 7126 |
|
|
2015
Q3 | $0 | Sell |
1
-3
| -75% | -$389 | ﹤0.01% | 7500 |
|
|
2015
Q2 | $1K | Buy |
4
+3
| +300% | +$695 | ﹤0.01% | 7159 |
|
|
2015
Q1 | $0 | Sell |
1
-123
| -99% | -$43.8K | ﹤0.01% | 7720 |
|
|
2014
Q4 | $50K | Buy |
+124
| New | +$32.4K | ﹤0.01% | 6345 |
|
Other funds holding CALA
Bank of America's CALA Position: Q1 2023 in Review
Bank of America sold out of Calithera Biosciences, Inc (CALA) in Q1 2023, closing a stake of 539 shares — an estimated $1.76K sold.
Bank of America first reported a position in CALA in Q4 2014 and held it in 29 quarters. The position peaked at $522K in Q1 2019. 2 funds tracked by Wall St. Rank hold CALA as of Q1 2023.
- Bank of America reported no remaining Calithera Biosciences, Inc position as of Q1 2023 after selling out during the quarter.
- Bank of America sold 539 Calithera Biosciences, Inc shares in Q1 2023, an estimated $1.76K.
- Bank of America first reported a position in Calithera Biosciences, Inc in Q4 2014 and held it in 29 quarters.
- Bank of America's Calithera Biosciences, Inc position peaked at $522K in Q1 2019.
- 2 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q1 2023.
Based on Bank of America's 13F filing for Q1 2023, filed 12 May 2023.